Genomic sequencing and biotechnology innovation by PacBio
PacBio launches 2026 Fiber-seq SMRT Grant for plant and animal research
Pacific Biosciences of California has announced that applications are now open for the 2026 PacBio Fiber-seq SMRT Grant. The grant will award up to two winners with free sequencing services using ...
Pacific Biosciences of California enables up to 12 RNA libraries in 1.5 days with Kinnex prep kits
Pacific Biosciences of California has launched new Kinnex prep kits for RNA sequencing, allowing up to 8 to 10 samples on a single Revio SMRT Cell when using the 12-fold kit and 6 samples with the ...
HiFi sequencing available for biopharma R and D, Pacific Biosciences of California unveils
Pacific Biosciences of California has announced the availability of its HiFi sequencing technology for biopharma and biotech research and development. The company is inviting industry experts to ...
Pacific Biosciences of California applies Kivvi with PacBio HiFi data to detect all 11 contracted D4Z4 alleles
Pacific Biosciences of California announced that all 11 contracted D4Z4 alleles were detected using the Kivvi tool with PacBio HiFi data. According to a recent preprint, Kivvi enables detailed ...
Pacific Biosciences of California powers single cell atlas spanning 26 human tissues
Pacific Biosciences of California has announced new findings supported by PacBio HiFi sequencing, highlighting advancements in rare disease research. Of particular note is a 12.1 percent ...
Pacific Biosciences of California supports undiagnosed disease hackathon in Singapore with sequencing technology
Pacific Biosciences of California contributed its HiFi whole-genome and RNA sequencing capabilities to the 5th Undiagnosed Hackathon held in Singapore. The event gathered 140 participants from ...
Pacific Biosciences of California launches large scale full length RNA sequencing initiative
Pacific Biosciences of California has announced a collaboration with tychobio_ai to advance AI-driven RNA therapeutics for rare diseases. The company will utilize its PacBio HiFi and Kinnex ...
Pacific Biosciences of California unveils Vega SPRQ-Nx to expand HiFi sequencing for biopharma
Pacific Biosciences of California has launched Vega SPRQ-Nx, aiming to make HiFi sequencing more accessible for biopharma research. The new offering is designed to enable lower DNA input, generate ...
Pacific Biosciences of California enables large scale microbial genomics with Vega SPRQ-Nx system
Pacific Biosciences of California announced that its Vega SPRQ-Nx platform can process up to 384 microbial de novo assembly samples, 96 shotgun metagenomic profiling communities, or 1,536 Kinnex ...
Pacific Biosciences of California unveils Vega SPRQ-Nx chemistry delivering 50 percent more HiFi data
Pacific Biosciences of California announced the launch of its Vega expert session, introducing SPRQ-Nx chemistry that delivers 50 percent more HiFi data, reaching up to 90 Gb per run. The upgrade ...
Pacific Biosciences of California releases HiFi Playbook highlighting streamlined therapeutic research
Pacific Biosciences of California has announced the launch of Vega SPRQ-Nx chemistry for its sequencing platforms, aiming to deliver higher data output, reduced DNA input requirements, and faster ...
Pacific Biosciences of California CEO explores future of long-read sequencing for newborn screening
Pacific Biosciences of California CEO Mark Van Oene appeared on Mendelspod this week to discuss the transformative potential of long-read sequencing in newborn screening. Van Oene examined how ...
Pacific Biosciences of California launches rapid end-to-end genomic sequencing solution
Pacific Biosciences of California has introduced a rapid, end-to-end HiFi whole genome sequencing (WGS) workflow that delivers genome-wide variant calls in less than 30 hours. The new solution is ...
Pacific Biosciences of California unveils webinar on long-read multiomics breakthrough in human disease research
Pacific Biosciences of California is hosting a webinar to explore how long-read multiomics is transforming human disease research. The event will address how leading scientists are combining ...
Pacific Biosciences of California streamlines genomics workflows with rapid setup quiz
Pacific Biosciences of California has introduced a rapid online quiz designed to help researchers identify optimal setups for their sequencing projects in under a minute. The tool guides users ...
Pacific Biosciences of California promotes high accuracy HiFi sequencing to power AI driven drug discovery
Pacific Biosciences of California is advancing the integration of artificial intelligence in drug discovery by emphasizing the need for robust, high quality data. The company advocates that its ...
HiFi sequencing expands detection with hybrid capture, Pacific Biosciences of California claims
Pacific Biosciences of California advocates for using hybrid capture in targeted HiFi sequencing, especially when working with larger panels, custom target designs, or shifting from short-read ...
Pacific Biosciences of California drives surge in complete genome assemblies with Cell special issue
Pacific Biosciences of California announces a major development in genomics as a new Cell special issue compiles research on complete genome assemblies. Thirteen papers featured in the issue ...
Pacific Biosciences of California introduces rapid quiz for tailored sequencing strategy guidance
Pacific Biosciences of California has unveiled a new HiFi Fit Kit designed to help researchers select optimal sequencing strategies in under a minute. Users can answer three targeted questions ...
Pacific Biosciences of California compares Illumina TruPath and PacBio HiFi WGS using HG002 benchmark
Pacific Biosciences of California is examining how Illumina TruPath performs against its own PacBio HiFi whole genome sequencing technology using publicly available HG002 benchmark data. The ...
CHU Nîmes implements PacBio PureTarget, bringing clinical repeat expansion testing online rapidly
Pacific Biosciences of California reports that CHU Nîmes in France has adopted PacBio PureTarget and transitioned to routine clinical use within approximately three months. This rapid ...
